EQS-News: CompuGroup Medical SE & Co. KGaA
/ Key word(s): Miscellaneous
CGM registers significant increase in issued e-prescriptions Koblenz. The digitization of the German healthcare system is gaining more momentum: Last week, 715,000 e-prescriptions were issued in the Ambulatory Information Systems of CompuGroup Medical (CGM) alone. This represents an increase of 45 percent compared to the previous week. In the two-month period to and including December 10, a total of 2.7 million e-prescriptions were issued via CGM's Ambulatory Information Systems. E-prescriptions are redeemed via electronic health card, gematik app, CGM's CLICKDOC mobile solution, or by printing the data matrix code. "The strong increase of e-prescriptions shows: The digitization of the German healthcare system is making significant progress. With electronic prescriptions, it is now reaching all patients. CompuGroup Medical is driving this development in many ways. We are currently working intensively to support practice teams in introducing e-prescriptions and setting up convenient signature procedures. We offer a wide range of consulting services for new processes in the interaction between practices and software. Our core understanding is to be a partner at the physician's side," says Dr. Ulrich Thomé, Managing Director Ambulatory Information Systems DACH at CGM. Dr. Beatrice Staudt, general practitioner and CGM user from Berlin, comments on the electronic prescription as follows: "Electronic prescribing significantly accelerates practice processes. It leads to greater safety in patient care. It takes the pressure off my practice team and our patients. I am pleased that digitization is advancing in the healthcare sector. The electronic doctor's letter and video consultation have also proved to be particularly helpful in my practice." According to gematik, a total of 13.3 million e-prescriptions have now been issued in Germany. The number has more than doubled in the last two months. The amount of medical facilities that issue e-prescriptions on a weekly basis has also more than doubled and currently stands at 35,000. 17,300 - almost all - pharmacies accepted e-prescriptions last week.
14.12.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Phone: | +49 (0)160 3630362 |
Fax: | +49 (0)261 8000 3200 |
E-mail: | investor@cgm.com |
Internet: | www.cgm.com |
ISIN: | DE000A288904 |
WKN: | A28890 |
Indices: | SDAX, TecDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1796915 |
End of News | EQS News Service |
|
1796915 14.12.2023 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.